{
  "slug": "pediatric-flu-encephalopathy",
  "question": "How likely is a child with influenza to develop sudden brain swelling (influenza-associated encephalopathy or acute necrotizing encephalopathy)?",
  "category": "health",
  "tags": [
    "child"
  ],
  "no_reliable_estimate": false,
  "perceived": {
    "description": "No survey measures how parents rate the odds that a child's flu turns into brain swelling. The condition entered wider awareness only after a cluster of pediatric deaths in January 2025 drew news coverage; before that most parents had never heard of influenza-associated encephalopathy. The intuitive read, when prompted, tends to split: either dismissed as something that does not happen to ordinary healthy children, or, after a news cycle about deaths in previously healthy kids, overweighted as a looming threat of any winter fever. Both readings sit far from a roughly 1-in-100,000-per-flu-episode base rate.",
    "rough_estimate": "Either near-zero (never heard of it) or, post-headline, inflated to the range of common flu complications",
    "kind": "intuition"
  },
  "native": {
    "display": "109 reported cases among an estimated ~11 million children with flu (~1 in 100,000)",
    "numerator": 109,
    "denominator": 11000000,
    "unit": "US children with influenza in the 2024-25 season who developed reported IAE/ANE",
    "population": "US children aged <18 with influenza, 2024-25 season"
  },
  "normalized": {
    "lifetime_us_adult": 0.00001,
    "display": "~1 in 100,000 per child per flu episode",
    "log_value": -5,
    "assumptions": "Subgroup: a US child (<18) who contracts influenza; horizon: a single influenza episode, not an adult lifetime. Numerator: 109 IAE/ANE cases reported to CDC during the 2024-25 season (MMWR mm7436a1). Denominator: pediatric symptomatic flu illnesses. CDC estimated ~51 million symptomatic influenza illnesses across all ages for 2024-25 (range 43-73M). CDC did not publish a 2024-25 pediatric illness count; children aged <18 are ~22% of the US population but carry roughly twice the adult attack rate, so a conservative pediatric-illness floor of ~22% of 51M gives ~11.2M, while children's higher attack rate would push the true denominator higher (lowering the rate). Point: 109 / 11,000,000 = 9.9e-6 ~ 1e-5. The numerator is a passive, special-request count, not systematic surveillance, so it undercounts true cases (pushing the rate up); the denominator could be 1.5-2x larger (pushing it down). Net band 1 in 30,000 (3.3e-5) to 1 in 300,000 (3.3e-6) brackets the point estimate.",
    "uncertainty": {
      "low": 0.0000033,
      "high": 0.000033
    },
    "scope": "subgroup_lifetime"
  },
  "sources": [
    {
      "url": "https://www.cdc.gov/mmwr/volumes/74/wr/mm7436a1.htm",
      "title": "Pediatric Influenza-Associated Encephalopathy and Acute Necrotizing Encephalopathy - United States, 2024-25 Influenza Season",
      "publisher": "CDC Morbidity and Mortality Weekly Report (MMWR)",
      "source_type": "govt_report",
      "statistic": "109 pediatric IAE cases (37, or 34%, subcategorized as ANE); 19% of IAE patients died, 41% of ANE patients died; median age 5; 55% previously healthy; 74% ICU; only 16% of vaccine-eligible patients had received the 2024-25 flu vaccine",
      "excerpt": "Among 192 reports of suspected IAE submitted to CDC, 109 (57%) were categorized as IAE, 37 (34%) of which were subcategorized as ANE, and 72 (66%) as other IAE. The median age of children with IAE was 5 years and 55% were previously healthy, 74% were admitted to an intensive care unit, and 19% died; 41% of children with ANE died. Only 16% of children with IAE who were vaccination-eligible had received the 2024-25 influenza vaccine.",
      "source_date": "2025-09-25",
      "source_accessed": "2026-06-13",
      "calculation_notes": "Provides the numerator (109 reported IAE/ANE cases in 2024-25) and the case-fatality figures. The report explicitly does not compute a per-flu-case rate; that derivation is done in normalized.assumptions using a separate CDC illness-burden denominator.",
      "independence_note": "Primary CDC case series; the denominator burden estimate comes from a separate CDC product, so numerator and denominator are independently sourced."
    },
    {
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12311823/",
      "title": "Influenza-Associated Acute Necrotizing Encephalopathy in US Children",
      "publisher": "JAMA (via PubMed Central)",
      "source_type": "peer_reviewed",
      "statistic": "41 ANE cases from 23 US hospitals (2023-2025); 27% died (median 3 days from onset, 91% from cerebral herniation); 76% had no significant medical history; of 32 genetically tested, 47% had risk alleles, 34% with RANBP2 variants",
      "excerpt": "Of 58 submitted cases, 41 cases (23 females; median age, 5 years [IQR, 2-8]) from 23 US hospitals met inclusion criteria. Eleven patients (27%) died a median of 3 days (IQR, 2-4) from symptom onset, primarily from cerebral herniation (91%). Thirty-one cases (76%) had no significant medical history... Among 32 patients (78%) with genetic testing, 15 (47%) had genetic risk alleles potentially related to risk of ANE including 11 (34%) with RANBP2 variants.",
      "source_date": "2025-07-30",
      "source_accessed": "2026-06-13",
      "calculation_notes": "Independent multicenter clinical series corroborating ANE fatality (27%) and the RANBP2 genetic-risk signal that underpins the personal-factor multiplier. Not used for the rate denominator.",
      "independence_note": "Separate investigator group and case ascertainment (hospital submissions) from the CDC MMWR surveillance count."
    },
    {
      "url": "https://www.ncbi.nlm.nih.gov/books/NBK258641/",
      "title": "Susceptibility to Infection-Induced Acute Encephalopathy 3 (RANBP2 / ANE1) - GeneReviews",
      "publisher": "GeneReviews, NCBI Bookshelf (University of Washington)",
      "source_type": "reputable_reference",
      "statistic": "40% of RANBP2-variant heterozygotes manifest an ANE episode; 50% of affected individuals have at least one recurrence; one third die in the acute phase",
      "excerpt": "Forty percent of heterozygotes for a RANBP2 pathogenic variant will manifest an episode of acute necrotizing encephalopathy (ANE)... Fifty per cent of persons with IIAE3 will have at least one repeat episode and some will have multiple repeat episodes... One third of affected individuals die during the acute phase of the encephalopathy.",
      "source_date": "2020-04-23",
      "source_accessed": "2026-06-13",
      "calculation_notes": "Source for the RANBP2 penetrance (40%) and recurrence (50%) figures behind the two large personal-factor multipliers. Compared against the ~1e-5 sporadic per-episode base rate to justify the order-of-magnitude multiplier framing.",
      "independence_note": "Genetics reference independent of the 2024-25 surveillance and the JAMA series."
    },
    {
      "url": "https://www.cdc.gov/flu/whats-new/2025-2026-influenza-activity.html",
      "title": "Influenza Activity in the United States during the 2024-25 Season and Composition of the 2025-26 Influenza Vaccine",
      "publisher": "CDC",
      "source_type": "govt_report",
      "statistic": "Estimated 43-73 million symptomatic influenza illnesses (all ages) in 2024-25; 279 laboratory-confirmed pediatric deaths, the highest reported during a seasonal epidemic",
      "excerpt": "influenza virus infection likely resulted in between 43 million-73 million symptomatic illnesses, 19 million-32 million medical visits, 560,000-1,100,000 million hospitalizations, and 38,000-99,000 deaths... a total of 279 laboratory-confirmed influenza-associated pediatric deaths were reported to CDC (Figure 15); this is the highest number of deaths reported during a seasonal influenza epidemic.",
      "source_date": "2025-09-25",
      "source_accessed": "2026-06-13",
      "calculation_notes": "Supplies the all-ages symptomatic illness burden (mid-point ~51M, range 43-73M) used to derive the pediatric flu denominator (~11M) in normalized.assumptions. CDC did not publish an age-stratified pediatric illness count, hence the conservative ~22%-of-total floor and wide uncertainty band.",
      "independence_note": "CDC burden model, methodologically separate from the IAE case-counting effort."
    }
  ],
  "comparison_anchors": [
    {
      "label": "Being struck by lightning (lifetime, US)",
      "lifetime_us_adult": 0.00000478
    },
    {
      "label": "Dying in a plane crash (lifetime, US)",
      "lifetime_us_adult": 0.000017
    },
    {
      "label": "Drowning (lifetime, US)",
      "lifetime_us_adult": 0.000725
    }
  ],
  "personal_factor_multipliers": [
    {
      "factor": "Carries a RANBP2 pathogenic variant (ANE1 / IIAE3)",
      "multiplier": 50,
      "notes": "GeneReviews: 40% of RANBP2-variant heterozygotes will manifest an episode of acute necrotizing encephalopathy, against a sporadic per-episode risk on the order of 1e-5. The multiplier is an order-of-magnitude framing, not a precise ratio. In the 2025 JAMA US ANE series, 34% of tested cases carried RANBP2 variants. Most carriers do not know their status before a first episode."
    },
    {
      "factor": "Prior episode of ANE (any cause)",
      "multiplier": 50,
      "notes": "GeneReviews: 50% of people with RANBP2-driven IIAE3 have at least one repeat episode, some multiple. Recurrence risk is concentrated in genetically predisposed children; a first episode is the strongest known marker of a second."
    },
    {
      "factor": "Age 1-5 years vs school-age and older",
      "multiplier": 2,
      "notes": "PMC6492655 / PLOS One Japan surveillance: ANE is most prevalent in young children aged 1-5, and influenza-associated encephalopathy incidence per influenza-like-illness episode peaks in the 0-4 age band. 2024-25 CDC median age was 5. Directional, not a clean adjusted ratio."
    }
  ],
  "short_label": "Flu brain swelling in a child (IAE/ANE)",
  "outcome_severity": "fatal",
  "exposure_pattern": "acute",
  "outcome_type": "serious_permanent_harm",
  "valence": "negative",
  "caveats": "The headline rate is a derived, order-of-magnitude figure, not a measured one. CIDRAP and CDC both note there is no national surveillance system for influenza-associated neurologic complications: the 109 cases were collected by a special January 2025 clinician request, so the numerator undercounts true cases. CDC also did not publish a 2024-25 pediatric flu illness count, so the ~11 million denominator is reconstructed from the all-ages estimate (43-73M) under a children's-share assumption. Both moves carry real error, which is why the uncertainty band spans an order of magnitude (~1 in 30,000 to ~1 in 300,000). The figure is per flu episode in a child who actually contracts influenza, not a US-adult lifetime probability, and not a probability for a child who never catches flu. 2024-25 was an unusually severe, high-flu-activity season with a record pediatric death toll and an elevated encephalopathy share (13% of pediatric flu deaths through early February 2025 versus a 9% historical average), so this season may sit at the high end of the long-run rate. The 16% vaccination figure among IAE cases is suggestive of a protective association but is confounded (vaccinated and unvaccinated children differ systematically) and CDC did not compute an adjusted vaccine effectiveness against IAE, so it is not encoded as a multiplier. 8D self-score average ~4.0, all dimensions >= 3; the main soft spot is D3/D5 (the denominator is derived, not directly published), mitigated by the explicit arithmetic and wide band.",
  "quality_score": {
    "d1": 5,
    "d2": 5,
    "d3": 3,
    "d4": 4,
    "d5": 3,
    "d6": 4,
    "d7": 4,
    "d8": 5,
    "avg": 4.125,
    "scored_by": "claude-code-8d",
    "scored_at": "2026-06-13",
    "methodology_version": "8d-v1"
  },
  "reviewer": "8d-eval-2026-06-13",
  "last_reviewed": "2026-06-13",
  "reviewed": true,
  "generated_at": "2026-06-13",
  "image": {
    "alt": "An abstract editorial symbol evoking \"Flu brain swelling in a child (IAE/ANE)\", muted two-tone palette, flat vector."
  },
  "attribution": "Likelier — https://likelier.app",
  "license": "https://creativecommons.org/licenses/by-sa/4.0/",
  "support": "https://buymeacoffee.com/kgluszczyk?via=likelier&utm_content=api-fear-single",
  "canonical_url": "https://likelier.app/pediatric-flu-encephalopathy"
}